跳至主要内容
临床试验/CTRI/2024/05/067160
CTRI/2024/05/067160尚未招募2 期

Effectiveness of individualized homoeopathic treatment in atopic dermatitis and its impact on the quality of life:An open label prospective, clinical study - NI

ational Institute of Homoeopathy0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Individuals diagnosed with atopic dermatitis who meet the Diagnostic Criteria established by Hanifin and Rajka.
  • Patients of any gender, religious affiliation and socio-economic conditions.
  • Patients aged between 16 to 65 years.
  • Patients who are ready to provide written informed consent for participation in the study.

排除标准

  • Individuals with diagnosed unstable mental or psychiatric conditions, severe systemic disorders, or life-threatening infections will be excluded from the study.
  • Patients currently undergoing treatment for Atopic Dermatitis with other therapies.
  • Pregnant and breastfeeding women, will also not be eligible for participation.

研究者

发起方
ational Institute of Homoeopathy

相似试验